Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | MEN1 | O00255 | 2/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | GGT1 | P19440 | 1/20 | 0.56 |
| ▸ | THRB | P10828 | 1/20 | 0.56 |
| ▸ | ARG1 | P05089 | 1/20 | 0.50 |
| ▸ | ARG2 | P78540 | 1/20 | 0.50 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | BLM | P54132 | 2/20 | 0.39 |
| ▸ | ESR1 | P03372 | 1/20 | 0.39 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.38 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL473835 | 1.00 | ALDH1A1 (0.56) | ALDH1A1MEN1CYP1A2KMT2AGGT1 | |
| SCHEMBL200536 | 1.00 | ALDH1A1 (0.56) | ALDH1A1MEN1CYP1A2KMT2AGGT1 | |
| Water SCHEMBL434488 | 0.98 | ALDH1A1 (0.54) | ALDH1A1MEN1CYP1A2KMT2AGGT1 | |
| Water SCHEMBL10780975 | 0.98 | ALDH1A1 (0.54) | ALDH1A1MEN1CYP1A2KMT2AGGT1 | |
| Water SCHEMBL10780977 | 0.98 | ALDH1A1 (0.54) | ALDH1A1MEN1CYP1A2KMT2AGGT1 | |
| SCHEMBL1300781 | 0.86 | ARG1 (0.57) | ALDH1A1MEN1CYP1A2KMT2AGGT1 | |
| SCHEMBL9003618 | 0.86 | ARG1 (0.57) | ALDH1A1MEN1CYP1A2KMT2AGGT1 | |
| 1-Aminocyclopropane Carboxylic Acid SCHEMBL15398008 | 0.84 | ALDH1A1 (0.47) | ALDH1A1MEN1CYP1A2KMT2AGGT1 | |
| SCHEMBL8687592 | 0.84 | GGT1 (0.65) | ALDH1A1MEN1CYP1A2KMT2AGGT1 | |
| D-Glutamate SCHEMBL28847437 | 0.83 | CYP1A2 (0.62) | ALDH1A1MEN1CYP1A2KMT2AGGT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1793 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012010851-A1 | CAPILLARY ELECTROPHORESIS OF CARBOHYDRATES | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2012-01-26 | — | — | WO | claimed |
| EP-1737884-A4 | ALPHA HELICAL MIMICS, THEIR USES AND METHODS FOR THEIR PRODUCTION | UNIV QUEENSLAND (AU) | 2008-10-29 | — | — | EP | claimed |
| US-20070197430-A1 | Conjugates And Therapeutic Uses Thereof | THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH (AU) | 2007-08-23 | — | — | US | claimed |
| US-7256172-B1 | Method of treatment and agents useful for same | THE UNIVERSITY OF MELBOURNE (AU) | 2007-08-14 | — | — | US | claimed |
| US-20070032417-A1 | Peptides and therapeutic uses thereof | WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH (AU) | 2007-02-08 | — | — | US | claimed |
| EP-1737884-A1 | ALPHA HELICAL MIMICS, THEIR USES AND METHODS FOR THEIR PRODUCTION | The University of Queensland (AU) | 2007-01-03 | — | — | EP | claimed |
| WO-2005090388-A1 | ALPHA HELICAL MIMICS, THEIR USES AND METHODS FOR THEIR PRODUCTION | THE UNIVERSITY OF QUEENSLAND (AU) | 2005-09-29 | — | — | WO | claimed |
| WO-2004058804-A1 | PEPTIDES AND THERAPEUTIC USES THEREOF | WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH (AU) | 2004-07-15 | — | — | WO | claimed |
| EP-0323267-B1 | Thermoplastic polyetherester copolymers | KOLON INC (KR) | 1995-02-15 | — | — | EP | claimed |
| US-4767827-A | ESTER INTERCHANGE, AMINOLYSIS | AJINOMOTO CO., INC. (JP) | 1988-08-30 | — | — | US | claimed |
| US-4507356-A | Moisture-permeable sheets | ADERANS COMPANY, LTD. (JP) | 1985-03-26 | — | — | US | claimed |
| WO-2026085582-A1 | PROTEIN CAGES | THE UNIVERSITY OF SYDNEY (AU) | 2026-04-30 | — | — | WO | disclosed |
| US-12589087-B2 | Enantiomer selective action on neurotransmission | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2026-03-31 | — | — | US | disclosed |
| EP-4627079-A2 | THERMOSTABLE BINDING SCAFFOLDS | Nectagen, Inc. (US) | 2025-10-08 | — | — | EP | disclosed |
| CN-120202191-A | Inhibitors of prostate specific membrane antigen and uses thereof | 上海先通生物科技有限公司 | 2025-06-24 | — | — | CN | disclosed |
| WO-1994028014-A2 | PEPTIDE INHIBITORS OF UROKINASE RECEPTOR ACTIVITY | CHIRON CORPORATION (US) | 1994-12-08 | — | — | WO | disclosed |
| WO-1994011388-A1 | SUPPORT FOR THE SYNTHESIS OF MODULAR POLYMERS | CHIRON MIMOTOPES PTY. LTD. (AU) | 1994-05-26 | — | — | WO | disclosed |
| WO-1994003483-A1 | ENDOTHELIN RECEPTOR-BINDING COMPOUNDS | CHIRON CORPORATION (US) | 1994-02-17 | — | — | WO | disclosed |
| EP-0275278-A1 | PEPTIDE FRAGMENTS OF ORGAN-SPECIFIC NEOANTIGENS | BIO-RAD LABORATORIES, INC. (US) | 1988-07-27 | — | — | EP | disclosed |
| WO-1988000344-A1 | PEPTIDE FRAGMENTS OF ORGAN-SPECIFIC NEOANTIGENS | BIO-RAD LABORATORIES, INC. (US) | 1988-01-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070032417-A1 | Peptides and therapeutic uses thereof | BCL2, BAX, BCL2L13 | ALDH1A1 4834/4885MEN1 2064/4885CYP1A2 4867/4885 |
| US-20070197430-A1 | Conjugates And Therapeutic Uses Thereof | BCL2, BAX, BAD | ALDH1A1 4519/4885MEN1 1894/4885CYP1A2 4822/4885 |
| US-12589087-B2 | Enantiomer selective action on neurotransmission | SLC1A2, GLUL, SLC6A13 | ALDH1A1 147/4885MEN1 3813/4885CYP1A2 296/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.